Osteitis condensans affecting two or more distinct skeletal sites simultaneously, classified under other disorders of bone density and structure (M85 category).

Documentation tips

What should appear in the chart to support M85.39.

Source · Editorial brief grounded in 6 cited references ↓

• Name each affected site explicitly in the assessment (e.g., 'osteitis condensans involving right ilium and left proximal tibia') — 'multiple sites' as a standalone phrase is acceptable but site-specific listing reduces audit risk.
• Include imaging findings that confirm sclerotic changes at each site: X-ray, CT, or MRI report references with descriptions of focal bone density increase.
• Document absence of infectious etiology (no fever, normal inflammatory markers, no periosteal reaction suggesting osteomyelitis) to differentiate from M86-series osteomyelitis codes.
• Note symptom status at each site — asymptomatic sclerosis found incidentally versus pain-associated lesions affects clinical justification for additional workup CPT codes billed alongside.
• If the patient is perimenopausal or postmenopausal, document that the sclerosis pattern is consistent with osteitis condensans rather than metastatic disease, supporting the benign classification.

Related CPT procedures

Procedure codes commonly billed with M85.39. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M85.39 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

• Assigning M85.39 when only one site is documented — if a single site is confirmed, drop to the corresponding site-specific code (e.g., M85.351 for right thigh) rather than defaulting to 'multiple sites.'
• Confusing osteitis condensans with osteomyelitis — the M86 series applies to infectious bone inflammation; M85.39 is a non-infectious sclerotic density change and the two blocks are clinically and code-structurally distinct.
• Failing to check the M85 Excludes1 list before assigning — polyostotic fibrous dysplasia (Q78.1) and osteopoikilosis (Q78.8) can mimic multi-site sclerotic changes and require different codes entirely.
• Using M85.30 (unspecified site) when the sites are documented but the coder defaults to unspecified — M85.39 is the correct code when multiple named sites appear in the record.
• Appending a 7th-character extension to M85.39 — this is a Chapter 13 M-code with no 7th-character requirement; adding one creates an invalid code.

Clinical context

Source · Editorial summary grounded in 6 cited references ↓

Sibling codes

Other billable codes under M85.3 (laterality / anatomic variants).